Beam Therapeutics Inc (BEAM) PT Raised to $47 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Alec W. Stranahan raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $47.00 (from $45.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
